Global Abdominal Aortic Aneurysm Drug Market Research Report 2021-2027

  • receipt Report ID : 215214
  • calendar_today Published On: May, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare

The Abdominal Aortic Aneurysm Drug market report offers in-dept analysis on the global market size, market share, market growth, sales analysis, regional analysis, market developments, opportunities, and forecasts that will help you in strategizing and expanding your business.

As per the most recent analysis conducted by our research team, the global Abdominal Aortic Aneurysm Drug market size is projected to reach US$ XX million by 2027 from US $ XX million in 2020 at a CAGR of XX% during 2021-2027.

The report included detailed analysis on the Abdominal Aortic Aneurysm Drug production capacity, its market share by manufacturers, growth rate, regional production capacity, ex-factory rate, and other important data points. The report also covers Abdominal Aortic Aneurysm Drug consumption globally as well as thorough bifurcation into regional and country wise consumption.

The research team goes an additional mile to comprehensively cover other important aspects on Abdominal Aortic Aneurysm Drug market such as the market dynamics, market segmentation, competition, growth prospects, and growth strategies. The buyers of this report will have access to exclusive data that covers market share by applications, manufacturers, regions, and countries. The document also covers market size by type, market competition by manufacturers, sales volume, growth rate, revenue, price and gross margins. Moreover, the authors of this report provide authentic calculations and estimations for global revenue and volume by type segments for Abdominal Aortic Aneurysm Drug market covering the period 2016-2027.

This report includes the following key manufacturers. We can also add other companies of your choice and customize the report as per your requirements.

  • AstraZeneca Plc
  • Carolus Therapeutics, Inc.
  • Novartis AG
  • Vida Therapeutics Inc.

Market Segment by Type

  • BSN-908
  • Canakinumab
  • CT-2009
  • Ticagrelor
  • Others

Market Segment by Application

  • Hospital
  • Clinic
  • Others

Market Segment by Regions and Countries

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, India, Japan, Taiwan, South Korea, Australia, Indonesia, Singapore, Malaysia, Rest of Asia-Pacific)
  • Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
  • Central & South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Turkey, Rest of Middle East & Africa)

The study objectives of this report are:

  • Overview of the Abdominal Aortic Aneurysm Drug market
  • Analysis on key market segments
  • Key manufacturer analysis based on production, sales, and revenue
  • Abdominal Aortic Aneurysm Drug market regional and country wise analysis for production and consumption
  • Study the forecast of market in respect to manufacturers, segments, and regions
  • Identify significant trends and factors driving the market growth
  • Analyse the available opportunities in the market by tracing high growth segments
  • Analyse competitive developments like acquisitions, expansions, product launches, agreements, etc.
  • Study the growth strategies of key manufacturers
  • SWOT analysis

In this study, the years considered to estimate the market size of Abdominal Aortic Aneurysm Drug are as follows:

History Year: 2016-2020

Base Year: 2020

Estimated Year: 2021

Forecast Year 2021 to 2027

Available Customizations

Market Research Place offers customizations according to the client's specific needs. The report can be customized on the basis of manufacturers, regions, applications, etc. Contact us to know more about the customization options.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Report Overview

1.1 Research Scope

1.2 Market Segment by Type

1.2.1 Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Type

1.2.2 BSN-908

1.2.3 Canakinumab

1.2.4 CT-2009

1.2.5 Ticagrelor

1.2.6 Others

1.3 Market Segment by Application

1.3.1 Global Abdominal Aortic Aneurysm Drug Market Share by Application (2016 VS 2021 VS 2027)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Abdominal Aortic Aneurysm Drug Market Size (2016-2027)

2.1.1 Global Abdominal Aortic Aneurysm Drug Revenue (2016-2027)

2.1.2 Global Abdominal Aortic Aneurysm Drug Sales (2016-2027)

2.2 Global Abdominal Aortic Aneurysm Drug Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027

2.2.1 Global Abdominal Aortic Aneurysm Drug Sales by Regions (2016-2021)

2.2.2 Global Abdominal Aortic Aneurysm Drug Revenue by Regions (2016-2021)

2.3 Global Abdominal Aortic Aneurysm Drug Market Size Forecast by Region

2.3.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Region (2022-2027)

2.3.2 Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Region (2022-2027)

2.4 Global Top Abdominal Aortic Aneurysm Drug Regions (Countries) Ranking by Market Size

2.5 Abdominal Aortic Aneurysm Drug Industry Trends

2.5.1 Abdominal Aortic Aneurysm Drug Market Trends

2.5.2 Abdominal Aortic Aneurysm Drug Market Drivers

2.5.3 Abdominal Aortic Aneurysm Drug Market Challenges

2.5.4 Abdominal Aortic Aneurysm Drug Market Restraints

3 Competitive Landscape by Manufacturers

3.1 Global Top Abdominal Aortic Aneurysm Drug Manufacturers by Sales (2016-2021)

3.1.1 Global Abdominal Aortic Aneurysm Drug Sales by Manufacturers (2016-2021)

3.1.2 Global Abdominal Aortic Aneurysm Drug Sales Market Share by Manufacturers (2016-2021)

3.1.3 Global 5 and 10 Largest Manufacturers by Abdominal Aortic Aneurysm Drug Sales in 2020

3.2 Global Top Manufacturers Abdominal Aortic Aneurysm Drug by Revenue

3.2.1 Global Abdominal Aortic Aneurysm Drug Revenue by Manufacturers (2016-2021)

3.2.2 Top Abdominal Aortic Aneurysm Drug Manufacturers Covered: Ranking by Revenue

3.2.3 Global Abdominal Aortic Aneurysm Drug Revenue Share by Manufacturers (2016-2021)

3.2.4 Global Abdominal Aortic Aneurysm Drug Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Abdominal Aortic Aneurysm Drug as of 2020)

3.4 Global Abdominal Aortic Aneurysm Drug Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers Abdominal Aortic Aneurysm Drug Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into Abdominal Aortic Aneurysm Drug Market

3.7 Key Manufacturers Abdominal Aortic Aneurysm Drug Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Abdominal Aortic Aneurysm Drug Market Size by Type

4.1 Global Abdominal Aortic Aneurysm Drug Historic Market Review by Type (2016-2021)

4.1.1 Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2016-2021)

4.1.2 Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2016-2021)

4.1.3 Abdominal Aortic Aneurysm Drug Price by Type (2016-2021)

4.2 Global Abdominal Aortic Aneurysm Drug Market Estimates and Forecasts by Type (2022-2027)

4.2.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Type (2022-2027)

4.2.2 Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Type (2022-2027)

4.2.3 Abdominal Aortic Aneurysm Drug Price Forecast by Type (2022-2027)

5 Global Abdominal Aortic Aneurysm Drug Market Size by Application

5.1 Global Abdominal Aortic Aneurysm Drug Historic Market Review by Application (2016-2021)

5.1.1 Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2016-2021)

5.1.2 Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2016-2021)

5.1.3 Abdominal Aortic Aneurysm Drug Price by Application (2016-2021)

5.2 Global Abdominal Aortic Aneurysm Drug Market Estimates and Forecasts by Application (2022-2027)

5.2.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Application (2022-2027)

5.2.2 Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Application (2022-2027)

5.2.3 Abdominal Aortic Aneurysm Drug Price Forecast by Application (2022-2027)

6 North America

6.1 North America Abdominal Aortic Aneurysm Drug Sales Breakdown by Company

6.1.1 North America Abdominal Aortic Aneurysm Drug Sales by Company (2016-2027)

6.1.2 North America Abdominal Aortic Aneurysm Drug Revenue by Company (2016-2027)

6.2 North America Abdominal Aortic Aneurysm Drug Market Size by Type (2016-2027)

6.2.1 North America Abdominal Aortic Aneurysm Drug Sales by Type (2016-2027)

6.2.2 North America Abdominal Aortic Aneurysm Drug Revenue by Type (2016-2027)

6.3 North America Abdominal Aortic Aneurysm Drug Market Size by Application (2016-2027)

6.3.1 North America Abdominal Aortic Aneurysm Drug Sales by Application (2016-2027)

6.3.2 North America Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2027)

6.4 North America Abdominal Aortic Aneurysm Drug Market Size by Country

6.4.1 North America Abdominal Aortic Aneurysm Drug Sales by Country (2016-2027)

6.4.2 North America Abdominal Aortic Aneurysm Drug Revenue by Country (2016-2027)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Abdominal Aortic Aneurysm Drug Sales Breakdown by Company

7.1.1 Europe Abdominal Aortic Aneurysm Drug Sales by Company (2016-2027)

7.1.2 Europe Abdominal Aortic Aneurysm Drug Revenue by Company (2016-2027)

7.2 Europe Abdominal Aortic Aneurysm Drug Market Size by Type (2016-2027)

7.2.1 Europe Abdominal Aortic Aneurysm Drug Sales by Type (2016-2027)

7.2.2 Europe Abdominal Aortic Aneurysm Drug Revenue by Type (2016-2027)

7.3 Europe Abdominal Aortic Aneurysm Drug Market Size by Application (2016-2027)

7.3.1 Europe Abdominal Aortic Aneurysm Drug Sales by Application (2016-2027)

7.3.2 Europe Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2027)

7.4 Europe Abdominal Aortic Aneurysm Drug Market Size by Country

7.4.1 Europe Abdominal Aortic Aneurysm Drug Sales by Country (2016-2027)

7.4.2 Europe Abdominal Aortic Aneurysm Drug Revenue by Country (2016-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

8 Asia Pacific

8.1 Asia Pacific Abdominal Aortic Aneurysm Drug Sales Breakdown by Company

8.1.1 Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Company (2016-2027)

8.1.2 Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Company (2016-2027)

8.2 Asia Pacific Abdominal Aortic Aneurysm Drug Market Size by Type (2016-2027)

8.2.1 Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Type (2016-2027)

8.2.2 Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Type (2016-2027)

8.3 Asia Pacific Abdominal Aortic Aneurysm Drug Market Size by Application (2016-2027)

8.3.1 Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Application (2016-2027)

8.3.2 Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2027)

8.4 Asia Pacific Abdominal Aortic Aneurysm Drug Market Size by Regions

8.4.1 Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Regions

8.4.2 Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Regions

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 India

8.4.7 Australia

8.4.8 Taiwan

8.4.9 Indonesia

8.4.10 Thailand

8.4.11 Malaysia

8.4.12 Philippines

8.4.13 Vietnam

9 Latin America

9.1 Latin America Abdominal Aortic Aneurysm Drug Sales Breakdown by Company

9.1.1 Latin America Abdominal Aortic Aneurysm Drug Sales by Company (2016-2027)

9.1.2 Latin America Abdominal Aortic Aneurysm Drug Revenue by Company (2016-2027)

9.2 Latin America Abdominal Aortic Aneurysm Drug Market Size by Type (2016-2027)

9.2.1 Latin America Abdominal Aortic Aneurysm Drug Sales by Type (2016-2027)

9.2.2 Latin America Abdominal Aortic Aneurysm Drug Revenue by Type (2016-2027)

9.3 Latin America Abdominal Aortic Aneurysm Drug Market Size by Application (2016-2027)

9.3.1 Latin America Abdominal Aortic Aneurysm Drug Sales by Application (2016-2027)

9.3.2 Latin America Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2027)

9.4 Latin America Abdominal Aortic Aneurysm Drug Market Size by Country

9.4.1 Latin America Abdominal Aortic Aneurysm Drug Sales by Country (2016-2027)

9.4.2 Latin America Abdominal Aortic Aneurysm Drug Revenue by Country (2016-2027)

9.4.3 Mexico

9.4.4 Brazil

9.4.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Breakdown by Company

10.1.1 Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Company (2016-2027)

10.1.2 Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Company (2016-2027)

10.2 Middle East and Africa Abdominal Aortic Aneurysm Drug Market Size by Type (2016-2027)

10.2.1 Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Type (2016-2027)

10.2.2 Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Type (2016-2027)

10.3 Middle East and Africa Abdominal Aortic Aneurysm Drug Market Size by Application (2016-2027)

10.3.1 Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Application (2016-2027)

10.3.2 Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2027)

10.4 Middle East and Africa Abdominal Aortic Aneurysm Drug Market Size by Country

10.4.1 Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Country (2016-2027)

10.4.2 Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Country (2016-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Company Profiles

11.1 AstraZeneca Plc

11.1.1 AstraZeneca Plc Corporation Information

11.1.2 AstraZeneca Plc Overview

11.1.3 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.1.4 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Products and Services

11.1.5 AstraZeneca Plc Abdominal Aortic Aneurysm Drug SWOT Analysis

11.1.6 AstraZeneca Plc Recent Developments

11.2 Carolus Therapeutics, Inc.

11.2.1 Carolus Therapeutics, Inc. Corporation Information

11.2.2 Carolus Therapeutics, Inc. Overview

11.2.3 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.2.4 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Products and Services

11.2.5 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug SWOT Analysis

11.2.6 Carolus Therapeutics, Inc. Recent Developments

11.3 Novartis AG

11.3.1 Novartis AG Corporation Information

11.3.2 Novartis AG Overview

11.3.3 Novartis AG Abdominal Aortic Aneurysm Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.3.4 Novartis AG Abdominal Aortic Aneurysm Drug Products and Services

11.3.5 Novartis AG Abdominal Aortic Aneurysm Drug SWOT Analysis

11.3.6 Novartis AG Recent Developments

11.4 Vida Therapeutics Inc.

11.4.1 Vida Therapeutics Inc. Corporation Information

11.4.2 Vida Therapeutics Inc. Overview

11.4.3 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.4.4 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Products and Services

11.4.5 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug SWOT Analysis

11.4.6 Vida Therapeutics Inc. Recent Developments

12 Value Chain and Sales Channels Analysis

12.1 Abdominal Aortic Aneurysm Drug Value Chain Analysis

12.2 Abdominal Aortic Aneurysm Drug Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Abdominal Aortic Aneurysm Drug Production Mode & Process

12.4 Abdominal Aortic Aneurysm Drug Sales and Marketing

12.4.1 Abdominal Aortic Aneurysm Drug Sales Channels

12.4.2 Abdominal Aortic Aneurysm Drug Distributors

12.5 Abdominal Aortic Aneurysm Drug Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

List of Tables

Table 1. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)

Table 2. Major Manufacturers of BSN-908

Table 3. Major Manufacturers of Canakinumab

Table 4. Major Manufacturers of CT-2009

Table 5. Major Manufacturers of Ticagrelor

Table 6. Major Manufacturers of Others

Table 7. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)

Table 8. Global Market Abdominal Aortic Aneurysm Drug Market Size (US$ Million) by Region: 2016 VS 2021 VS 2027

Table 9. Global Abdominal Aortic Aneurysm Drug Sales by Region (2016-2021) & (K Pcs)

Table 10. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2016-2021)

Table 11. Global Abdominal Aortic Aneurysm Drug Revenue by Region (2016-2021) & (US$ Million)

Table 12. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2016-2021)

Table 13. Global Abdominal Aortic Aneurysm Drug Sales Forecast by Region (2022-2027) & (K Pcs)

Table 14. Global Abdominal Aortic Aneurysm Drug Sales Market Share Forecast by Region (2022-2027)

Table 15. Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Region (2022-2027) & (US$ Million)

Table 16. Global Abdominal Aortic Aneurysm Drug Revenue Market Share Forecast by Region (2022-2027)

Table 17. Top Abdominal Aortic Aneurysm Drug Regions (Countries) Ranking by Market Size (US$ Million) in 2020

Table 18. Abdominal Aortic Aneurysm Drug Market Trends

Table 19. Abdominal Aortic Aneurysm Drug Market Drivers

Table 20. Abdominal Aortic Aneurysm Drug Market Challenges

Table 21. Abdominal Aortic Aneurysm Drug Market Restraints

Table 22. Global Abdominal Aortic Aneurysm Drug Sales by Manufacturers (2016-2021) & (K Pcs)

Table 23. Global Abdominal Aortic Aneurysm Drug Sales Share by Manufacturers (2016-2021)

Table 24. Global Abdominal Aortic Aneurysm Drug Revenue by Manufacturers (2016-2021) & (US$ Million)

Table 25. Ranking of Global Top Abdominal Aortic Aneurysm Drug Manufacturers by Revenue (US$ Million) in 2020

Table 26. Abdominal Aortic Aneurysm Drug Revenue Share by Manufacturers (2016-2021)

Table 27. Global Abdominal Aortic Aneurysm Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Abdominal Aortic Aneurysm Drug as of 2020)

Table 29. Key Manufacturers Abdominal Aortic Aneurysm Drug Average Selling Price (ASP) & (2016-2021) & (USD/Pcs)

Table 30. Key Manufacturers Abdominal Aortic Aneurysm Drug Plants/Factories Distribution

Table 31. Key Manufacturers Abdominal Aortic Aneurysm Drug Area Served

Table 32. Date of Key Manufacturers Enter into Abdominal Aortic Aneurysm Drug Market

Table 33. Key Manufacturers Abdominal Aortic Aneurysm Drug Product Type

Table 34. Mergers & Acquisitions, Expansion Plans

Table 35. Global Abdominal Aortic Aneurysm Drug Sales (K Pcs) by Type (2016-2021)

Table 36. Global Abdominal Aortic Aneurysm Drug Sales Share by Type (2016-2021)

Table 37. Global Abdominal Aortic Aneurysm Drug Revenue (US$ Million) Market Share by Type (2016-2021)

Table 38. Global Abdominal Aortic Aneurysm Drug Price (K Pcs) by Type (2016-2021)

Table 39. Global Abdominal Aortic Aneurysm Drug Sales (K Pcs) by Type (2022-2027)

Table 40. Global Abdominal Aortic Aneurysm Drug Sales Share by Type (2022-2027)

Table 41. Global Abdominal Aortic Aneurysm Drug Revenue (US$ Million) Market Share by Type (2022-2027)

Table 42. Global Abdominal Aortic Aneurysm Drug Revenue Share by Type (2022-2027)

Table 43. Global Abdominal Aortic Aneurysm Drug Price (K Pcs) by Type (2022-2027)

Table 44. Global Abdominal Aortic Aneurysm Drug Sales (K Pcs) by Application (2016-2021)

Table 45. Global Abdominal Aortic Aneurysm Drug Sales Share by Application (2016-2021)

Table 46. Global Abdominal Aortic Aneurysm Drug Revenue (US$ Million) Market Share by Application (2016-2021)

Table 47. Global Abdominal Aortic Aneurysm Drug Price (K Pcs) by Application (2016-2021)

Table 48. Global Abdominal Aortic Aneurysm Drug Sales (K Pcs) by Application (2022-2027)

Table 49. Global Abdominal Aortic Aneurysm Drug Sales Share by Application (2022-2027)

Table 50. Global Abdominal Aortic Aneurysm Drug Revenue (US$ Million) Market Share by Application (2022-2027)

Table 51. Global Abdominal Aortic Aneurysm Drug Revenue Share by Application (2022-2027)

Table 52. Global Abdominal Aortic Aneurysm Drug Price (K Pcs) by Application (2022-2027)

Table 53. North America Abdominal Aortic Aneurysm Drug Sales by Company (2016-2021) & (K Pcs)

Table 54. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Company (2016-2021)

Table 55. North America Abdominal Aortic Aneurysm Drug Revenue by Company (2016-2021) & (US$ Million)

Table 56. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Company (2016-2021)

Table 57. North America Abdominal Aortic Aneurysm Drug Sales by Application (2016-2021) & (K Pcs)

Table 58. North America Abdominal Aortic Aneurysm Drug Sales by Application (2022-2027) & (K Pcs)

Table 59. North America Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2021) & (US$ Million)

Table 60. North America Abdominal Aortic Aneurysm Drug Revenue by Application (2022-2027) & (US$ Million)

Table 61. North America Abdominal Aortic Aneurysm Drug Sales by Application (2016-2021) & (K Pcs)

Table 62. North America Abdominal Aortic Aneurysm Drug Sales by Application (2022-2027) & (K Pcs)

Table 63. North America Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2021) & (US$ Million)

Table 64. North America Abdominal Aortic Aneurysm Drug Revenue by Application (2022-2027) & (US$ Million)

Table 65. North America Abdominal Aortic Aneurysm Drug Sales by Country (2016-2021) & (K Pcs)

Table 66. North America Abdominal Aortic Aneurysm Drug Sales by Country (2022-2027) & (K Pcs)

Table 67. North America Abdominal Aortic Aneurysm Drug Revenue by Country (2016-2021) & (US$ Million)

Table 68. North America Abdominal Aortic Aneurysm Drug Revenue by Country (2022-2027) & (US$ Million)

Table 69. Europe Abdominal Aortic Aneurysm Drug Sales by Company (2016-2021) & (K Pcs)

Table 70. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Company (2016-2021)

Table 71. Europe Abdominal Aortic Aneurysm Drug Revenue by Company (2016-2021) & (US$ Million)

Table 72. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Company (2016-2021)

Table 73. Europe Abdominal Aortic Aneurysm Drug Sales by Application (2016-2021) & (K Pcs)

Table 74. Europe Abdominal Aortic Aneurysm Drug Sales by Application (2022-2027) & (K Pcs)

Table 75. Europe Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2021) & (US$ Million)

Table 76. Europe Abdominal Aortic Aneurysm Drug Revenue by Application (2022-2027) & (US$ Million)

Table 77. Europe Abdominal Aortic Aneurysm Drug Sales by Application (2016-2021) & (K Pcs)

Table 78. Europe Abdominal Aortic Aneurysm Drug Sales by Application (2022-2027) & (K Pcs)

Table 79. Europe Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2021) & (US$ Million)

Table 80. Europe Abdominal Aortic Aneurysm Drug Revenue by Application (2022-2027) & (US$ Million)

Table 81. Europe Abdominal Aortic Aneurysm Drug Sales by Country (2016-2021) & (K Pcs)

Table 82. Europe Abdominal Aortic Aneurysm Drug Sales by Country (2022-2027) & (K Pcs)

Table 83. Europe Abdominal Aortic Aneurysm Drug Revenue by Country (2016-2021) & (US$ Million)

Table 84. Europe Abdominal Aortic Aneurysm Drug Revenue by Country (2022-2027) & (US$ Million)

Table 85. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Company (2016-2021) & (K Pcs)

Table 86. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Company (2016-2021)

Table 87. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Company (2016-2021) & (US$ Million)

Table 88. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Market Share by Company (2016-2021)

Table 89. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Application (2016-2021) & (K Pcs)

Table 90. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Application (2022-2027) & (K Pcs)

Table 91. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2021) & (US$ Million)

Table 92. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Application (2022-2027) & (US$ Million)

Table 93. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Application (2016-2021) & (K Pcs)

Table 94. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Application (2022-2027) & (K Pcs)

Table 95. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2021) & (US$ Million)

Table 96. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Application (2022-2027) & (US$ Million)

Table 97. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Region (2016-2021) & (K Pcs)

Table 98. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Region (2022-2027) & (K Pcs)

Table 99. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Region (2016-2021) & (US$ Million)

Table 100. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Region (2022-2027) & (US$ Million)

Table 101. Latin America Abdominal Aortic Aneurysm Drug Sales by Company (2016-2021) & (K Pcs)

Table 102. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Company (2016-2021)

Table 103. Latin America Abdominal Aortic Aneurysm Drug Revenue by Company (2016-2021) & (US$ Million)

Table 104. Latin America Abdominal Aortic Aneurysm Drug Revenue Market Share by Company (2016-2021)

Table 105. Latin America Abdominal Aortic Aneurysm Drug Sales by Application (2016-2021) & (K Pcs)

Table 106. Latin America Abdominal Aortic Aneurysm Drug Sales by Application (2022-2027) & (K Pcs)

Table 107. Latin America Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2021) & (US$ Million)

Table 108. Latin America Abdominal Aortic Aneurysm Drug Revenue by Application (2022-2027) & (US$ Million)

Table 109. Latin America Abdominal Aortic Aneurysm Drug Sales by Application (2016-2021) & (K Pcs)

Table 110. Latin America Abdominal Aortic Aneurysm Drug Sales by Application (2022-2027) & (K Pcs)

Table 111. Latin America Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2021) & (US$ Million)

Table 112. Latin America Abdominal Aortic Aneurysm Drug Revenue by Application (2022-2027) & (US$ Million)

Table 113. Latin America Abdominal Aortic Aneurysm Drug Sales by Country (2016-2021) & (K Pcs)

Table 114. Latin America Abdominal Aortic Aneurysm Drug Sales by Country (2022-2027) & (K Pcs)

Table 115. Latin America Abdominal Aortic Aneurysm Drug Revenue by Country (2016-2021) & (US$ Million)

Table 116. Latin America Abdominal Aortic Aneurysm Drug Revenue by Country (2022-2027) & (US$ Million)

Table 117. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Company (2016-2021) & (K Pcs)

Table 118. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Company (2016-2021)

Table 119. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Company (2016-2021) & (US$ Million)

Table 120. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Market Share by Company (2016-2021)

Table 121. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Application (2016-2021) & (K Pcs)

Table 122. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Application (2022-2027) & (K Pcs)

Table 123. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2021) & (US$ Million)

Table 124. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Application (2022-2027) & (US$ Million)

Table 125. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Application (2016-2021) & (K Pcs)

Table 126. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Application (2022-2027) & (K Pcs)

Table 127. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Application (2016-2021) & (US$ Million)

Table 128. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Application (2022-2027) & (US$ Million)

Table 129. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Country (2016-2021) & (K Pcs)

Table 130. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Country (2022-2027) & (K Pcs)

Table 131. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Country (2016-2021) & (US$ Million)

Table 132. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Country (2022-2027) & (US$ Million)

Table 133. AstraZeneca Plc Corporation Information

Table 134. AstraZeneca Plc Description and Overview

Table 135. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 136. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Product and Services

Table 137. AstraZeneca Plc Abdominal Aortic Aneurysm Drug SWOT Analysis

Table 138. AstraZeneca Plc Recent Developments

Table 139. Carolus Therapeutics, Inc. Corporation Information

Table 140. Carolus Therapeutics, Inc. Description and Overview

Table 141. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 142. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Product and Services

Table 143. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug SWOT Analysis

Table 144. Carolus Therapeutics, Inc. Recent Developments

Table 145. Novartis AG Corporation Information

Table 146. Novartis AG Description and Overview

Table 147. Novartis AG Abdominal Aortic Aneurysm Drug Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 148. Novartis AG Abdominal Aortic Aneurysm Drug Product and Services

Table 149. Novartis AG Abdominal Aortic Aneurysm Drug SWOT Analysis

Table 150. Novartis AG Recent Developments

Table 151. Vida Therapeutics Inc. Corporation Information

Table 152. Vida Therapeutics Inc. Description and Overview

Table 153. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 154. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Product and Services

Table 155. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug SWOT Analysis

Table 156. Vida Therapeutics Inc. Recent Developments

Table 157. Key Raw Materials Lists

Table 158. Raw Materials Key Suppliers Lists

Table 159. Abdominal Aortic Aneurysm Drug Distributors List

Table 160. Abdominal Aortic Aneurysm Drug Customers List

Table 161. Research Programs/Design for This Report

Table 162. Key Data Information from Secondary Sources

Table 163. Key Data Information from Primary Sources

List of Figures

Figure 1. Abdominal Aortic Aneurysm Drug Product Picture

Figure 2. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type in 2020 & 2027

Figure 3. BSN-908 Picture

Figure 4. Canakinumab Picture

Figure 5. CT-2009 Picture

Figure 6. Ticagrelor Picture

Figure 7. Others Picture

Figure 8. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application in 2020 & 2027

Figure 9. Hospital Use Case

Figure 10. Clinic Use Case

Figure 11. Others Use Case

Figure 12. Abdominal Aortic Aneurysm Drug Report Years Considered

Figure 13. Global Abdominal Aortic Aneurysm Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027

Figure 14. Global Abdominal Aortic Aneurysm Drug Market Size 2016-2027 (US$ Million)

Figure 15. Global Abdominal Aortic Aneurysm Drug Sales (2016-2021) & (K Pcs)

Figure 16. Global Abdominal Aortic Aneurysm Drug Market Size Market Share by Region: 2020 VS 2027

Figure 17. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2016-2021)

Figure 18. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region in 2020

Figure 19. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region in 2016 VS 2020

Figure 20. Global Abdominal Aortic Aneurysm Drug Sales Share by Manufacturers In 2020

Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Abdominal Aortic Aneurysm Drug Sales in 2020

Figure 22. Abdominal Aortic Aneurysm Drug Revenue Share by Manufacturers In 2020

Figure 23. Abdominal Aortic Aneurysm Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020

Figure 24. Global Abdominal Aortic Aneurysm Drug Revenue Share by Type (2016-2021)

Figure 25. Global Abdominal Aortic Aneurysm Drug Revenue Growth Rate by Type in 2016 & 2020

Figure 26. Global Abdominal Aortic Aneurysm Drug Revenue Share by Application (2016-2021)

Figure 27. Global Abdominal Aortic Aneurysm Drug Revenue Growth Rate by Application in 2016 & 2020

Figure 28. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2016-2027)

Figure 29. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2016-2027)

Figure 30. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2016-2027)

Figure 31. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2016-2027)

Figure 32. North America Abdominal Aortic Aneurysm Drug Sales Share by Country (2016-2027)

Figure 33. North America Abdominal Aortic Aneurysm Drug Revenue Share by Country (2016-2027)

Figure 34. U.S. Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 35. Canada Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 36. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2016-2027)

Figure 37. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2016-2027)

Figure 38. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2016-2027)

Figure 39. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2016-2027)

Figure 40. Europe Abdominal Aortic Aneurysm Drug Sales Share by Country (2016-2027)

Figure 41. Europe Abdominal Aortic Aneurysm Drug Revenue Share by Country (2016-2027)

Figure 42. Germany Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 43. France Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 44. U.K. Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 45. Italy Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 46. Russia Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 47. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2016-2027)

Figure 48. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2016-2027)

Figure 49. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2016-2027)

Figure 50. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2016-2027)

Figure 51. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Share by Region (2016-2027)

Figure 52. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Share by Region (2016-2027)

Figure 53. China Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 54. Japan Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 55. South Korea Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 56. India Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 57. Australia Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 58. Taiwan Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 59. Indonesia Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 60. Thailand Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 61. Malaysia Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 62. Philippines Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 63. Vietnam Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 64. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2016-2027)

Figure 65. Latin America Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2016-2027)

Figure 66. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2016-2027)

Figure 67. Latin America Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2016-2027)

Figure 68. Latin America Abdominal Aortic Aneurysm Drug Sales Share by Country (2016-2027)

Figure 69. Latin America Abdominal Aortic Aneurysm Drug Revenue Share by Country (2016-2027)

Figure 70. Mexico Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 71. Brazil Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 72. Argentina Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 73. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2016-2027)

Figure 74. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2016-2027)

Figure 75. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2016-2027)

Figure 76. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2016-2027)

Figure 77. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Share by Country (2016-2027)

Figure 78. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Share by Country (2016-2027)

Figure 79. Turkey Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 80. Saudi Arabia Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 81. UAE Abdominal Aortic Aneurysm Drug Revenue (2016-2027) & (US$ Million)

Figure 82. Abdominal Aortic Aneurysm Drug Value Chain

Figure 83. Abdominal Aortic Aneurysm Drug Production Process

Figure 84. Channels of Distribution

Figure 85. Distributors Profiles

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

Please fill the form below, to recieve the report sample


+1